The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

K.K. Laktionov

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

V.V. Breder

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

L.V. Bolotina

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of Ministry of Russia

L.Yu. Vladimirova

National Medical Research Center for Oncology of the Ministry of Health of Russia

M.G. Gordiev

OOO «NATIONAL BIOSERVICE»

I.A. Demidova

Moscow City Oncology Hospital No. 62

F.V. Moiseenko

Saint Petersburg Clinical Research and Practice Center of Specialized Medical Care in Oncology

S.V. Orlov

Acad. I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia

E.V. Reutova

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

N.A. Savelov

Moscow City Oncology Hospital No. 62

D.D. Sakaeva

Bashkir State Medical University

A.V. Smolin

Acad. N.N. Burdenko Main Military Clinical Hospital of the Ministry of Defense of Russia

ALK-, ROS1-, RET-, and NTRK-positive non-small cell lung cancer: diagnosis and targeted therapy. Resolution of the Expert Panel

Authors:

K.K. Laktionov, V.V. Breder, L.V. Bolotina, L.Yu. Vladimirova, M.G. Gordiev, I.A. Demidova, F.V. Moiseenko, S.V. Orlov, E.V. Reutova, N.A. Savelov, D.D. Sakaeva, A.V. Smolin

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2021;10(4): 41‑43

Views: 1021

Downloaded: 41


To cite this article:

Laktionov KK, Breder VV, Bolotina LV, Vladimirova LYu, Gordiev MG, Demidova IA, Moiseenko FV, Orlov SV, Reutova EV, Savelov NA, Sakaeva DD, Smolin AV. ALK-, ROS1-, RET-, and NTRK-positive non-small cell lung cancer: diagnosis and targeted therapy. Resolution of the Expert Panel. P.A. Herzen Journal of Oncology. 2021;10(4):41‑43. (In Russ.)
https://doi.org/10.17116/onkolog20211004141

Recommended articles:
Mole­cularly targeted therapy for biliary cancer. P.A. Herzen Journal of Onco­logy. 2024;(3):34-39
Comparison of three approaches to auto­somal rece­ssive diseases carrier screening. Russian Journal of Preventive Medi­cine. 2023;(10):36-42

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.